Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
Tajuelo A, Carretero O, García-Ríos E, López-Siles M, Cano O, Vázquez M, Más V, Rodríguez-Goncer I, Lalueza A, López-Medrano F, San Juan R, Fernández-Ruiz M, Aguado JM, McConnell MJ, Pérez-Romero P. Tajuelo A, et al. Among authors: carretero o. Front Immunol. 2022 Jun 30;13:965809. doi: 10.3389/fimmu.2022.965809. eCollection 2022. Front Immunol. 2022. PMID: 35990649 Free PMC article.
Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
Tajuelo A, Carretero O, García-Ríos E, López-Siles M, Cano O, Vázquez M, Más V, Rodríguez-Goncer I, Lalueza A, López-Medrano F, Juan RS, Fernández-Ruiz M, Aguado JM, McConnell MJ, Pérez-Romero P. Tajuelo A, et al. Among authors: carretero o. Front Immunol. 2022 Apr 25;13:878812. doi: 10.3389/fimmu.2022.878812. eCollection 2022. Front Immunol. 2022. PMID: 35547738 Free PMC article.
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection.
de la Calle C, Lalueza A, Mancheño-Losa M, Maestro-de la Calle G, Lora-Tamayo J, Arrieta E, García-Reyne A, Losada I, de Miguel B, Díaz-Simón R, López-Medrano F, Fernández-Ruiz M, Carretero O, San Juan R, Aguado JM, Lumbreras C. de la Calle C, et al. Among authors: carretero o. Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1209-1216. doi: 10.1007/s10096-020-04150-w. Epub 2021 Jan 7. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33409832 Free PMC article.
Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients.
Fernández-Ruiz M, Almendro-Vázquez P, Carretero O, Ruiz-Merlo T, Laguna-Goya R, San Juan R, López-Medrano F, García-Ríos E, Más V, Moreno-Batenero M, Loinaz C, Andrés A, Pérez-Romero P, Paz-Artal E, Aguado JM. Fernández-Ruiz M, et al. Among authors: carretero o. Transplant Direct. 2021 Nov 17;7(12):e794. doi: 10.1097/TXD.0000000000001246. eCollection 2021 Dec. Transplant Direct. 2021. PMID: 34805496 Free PMC article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: carretero o. Med Clin (Barc). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcli.2021.06.014. Epub 2021 Jun 18. Med Clin (Barc). 2022. PMID: 34243954 Free PMC article.
Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa.
Corbella L, Boán J, San-Juan R, Fernández-Ruiz M, Carretero O, Lora D, Hernández-Jiménez P, Ruiz-Ruigómez M, Rodríguez-Goncer I, Silva JT, López-Medrano F, Lizasoain M, Villa J, Caro-Teller JM, Aguado JM. Corbella L, et al. Among authors: carretero o. Int J Antimicrob Agents. 2022 Feb;59(2):106517. doi: 10.1016/j.ijantimicag.2021.106517. Epub 2022 Jan 3. Int J Antimicrob Agents. 2022. PMID: 34990760
Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study.
Corbella L, Fernández-Ruiz M, Ruiz-Ruigómez M, Rodríguez-Goncer I, Silva JT, Hernández-Jiménez P, López-Medrano F, Lizasoain M, Villa J, Carretero O, Aguado JM, San-Juan R. Corbella L, et al. Among authors: carretero o. Int J Infect Dis. 2022 Jun;119:59-68. doi: 10.1016/j.ijid.2022.03.025. Epub 2022 Mar 21. Int J Infect Dis. 2022. PMID: 35331934 Free article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: carretero o. Med Clin (Engl Ed). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcle.2021.06.025. Epub 2022 Jun 22. Med Clin (Engl Ed). 2022. PMID: 35761980 Free PMC article.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: carretero o. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
394 results